Click here to create your personal news page. The news that appears on Alkermes Inc. will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.  

topics : related - allExplore

Shopping Categories

  1. 1. Digital Camera
  2. 2. LCD Monitor
  3. 3. Mobile Phone
  4. 4. LCD TV
  5. 5. Laptop Computer
  6. 6. Graphic Card
  7. 7. Smartphone
  8. 8. Fridge
  9. 9. Freezer
  10. 10. Vacuum Cleaner
  11. 11. Digital Camcorder
  12. 12. Washing Machine
  13. 13. Processor
  14. 14. Microwave
  15. 15. Coffee Maker & Expresso

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Car/Motor Bike
  3. 3. Communication
  4. 4. Computers
  5. 5. Electronics
  6. 6. Entertainment
  7. 7. Fashion & Lingerie
  8. 8. Finance
  9. 9. Gifts & Gadgets
  10. 10. Health & Beauty
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Sport & Fitness
  14. 14. Travel
  15. 15. Video Games

Participate

News Categories



Alkermes Inc.



Sort by : relevance - date
+Vote!

Amylin, Alkermes sink on diabetes drug setback

Market Watch (Free subscription) | 04/11/2008

BOSTON (MarketWatch) -- Shares of partners Amylin Pharmaceuticals and Alkermes Inc. spiraled downward early Tuesday on news that U.S. regulators might require the companies to conduct another study for their long-acting diabetes product exenatide LAR. According to Alkermes, the Food and Drug Administration has determined that batches of the product produced at Amylin's commercial...

+Vote!

Biotech Stocks: Drug stocks mixed; Amylin, Alkermes tumble

Market Watch (Free subscription) | 04/11/2008

Drug stocks were mixed in early trading Tuesday, while shares of partners Amylin Pharmaceuticals and Alkermes Inc. tumbled on news that U.S. regulatory approval for their diabetes drug exenatide LAR could be delayed due to filing problems.

+Vote!

Drug stocks mixed; Amylin, Alkermes tumble on FDA setback

Market Watch (Free subscription) | 04/11/2008

BOSTON (MarketWatch) -- Drug stocks were mixed in early trading Tuesday, while shares of partners Amylin Pharmaceuticals and Alkermes Inc. tumbled on news that U.S. regulatory approval for their diabetes drug exenatide LAR could be delayed due to filing problems. The Amex Pharmaceutical Index inched up marginally to 271.47 as the Amex Biotechnology Index slid 0.8% to 678.90. Shares of...

+Vote!

Biotech Stocks: Drug stocks slide day after U.S. election

Market Watch (Free subscription) | 05/11/2008

... which is similar to Amylin's popular Byetta, is being co-developed with drug delivery specialist Alkermes Inc. ALKSand Eli Lilly & Co. LLYAlkermes shares, which were also hard hit on Tuesday, were trading largely flat at $9.12. Lilly shares were down nominally at $35.09. Val Brickates Kennedy is a reporter for MarketWatch in Boston.More Biotech Stocks stories12:52 PM 11/4/0811:39...

+Vote!

Version of Byetta May Face Delay

Law Blog - WSJ.com (Free subscription) | 04/11/2008

... by the drug's makers Tuesday morning, sending shares tumbling.At midday, Amylin Pharmaceuticals Inc. traded at $8.50 a share, down 21%. Alkermes Inc., of Cambridge, Mass., traded at $9.11, ... Share: Yahoo! Buzz facebook MySpace LinkedIn Digg del.icio.us NewsVine StumbleUpon Mixx Back To Email Newsletters and AlertsThe latest news and analysis delivered to your in-box. Check...

+Vote!

Biotech Stocks: Drug stocks, broader market slide on recession fears

Market Watch (Free subscription) | 27/10/2008

... all down at least 2%. In the U.S., several large-cap pharmaceutical makers lost ground. Pfizer Inc. PFE, Merck & Co. MRK, Eli Lilly & Co. LLYand Schering-Plough Corp. SGPwere the notable decliners, all down about 2%. Large- to mid-cap biotech issues also felt the chill. Amylin Pharmaceuticals AMLN, Alkermes Inc. ALKS, Alnylam Pharmaceuticals ALNYand Celera Corp. CRAall fell...